SecBot SecBot
8-K ·Filed Nov 9, 2026

TPB

Turning Point Brands, Inc.
MIXED
Impact 5/10
Horizonweeks Processed7d 17h ago SEC0001437749-26-035713
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The revenue beat and strong Modern Oral growth are positive, but the steep decline in profitability from heavy investment spending is a concern. Watch for the pace of margin improvement as Modern Oral scales and whether full-year adjusted EBITDA guidance of $70-$80M is achievable given the current run rate.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$63.26
T+0 close · Nov 9, 2026 · via day close
Latest settled
−21.48%
T+5 · $49.67
Vs SPY
−19.79%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $63.26entry
  2. T+1 · 7d ago −0.71%α −0.34% · $62.81
  3. T+5 · 18h ago −21.48%α −19.79% · $49.67
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Turning Point Brands reported Q3 2026 net sales of $151.1M (+27.0% YoY), beating the $147.8M consensus, and adjusted diluted EPS of $0.41, above the $0.32 consensus. However, GAAP net income fell 81.4% to $3.9M and adjusted EBITDA declined 41.3% to $18.4M as heavy sales and marketing investments in Modern Oral weighed on profitability. The company reaffirmed its full-year Modern Oral gross sales guidance of $330-$350M and adjusted EBITDA guidance of $70-$80M.

Key Financial Metrics

EPS (Adj.)
$0.41
est $0.32 · +28.1% · GAAP: $0.19
Revenue
$151.1M
est $147.8M · +2.2% · +27.0% YoY
Rating
beat
Guidance
$260M-$270M (Modern Oral net sales)
maintained
Free Cash Flow
$2.3M
Gross Margin
56.4%

Key Facts

  • Total net sales increased 27.0% YoY to $151.1M, above the $147.8M consensus.
  • Adjusted diluted EPS of $0.41 beat the $0.32 consensus.
  • GAAP net income attributable to TPB fell 81.4% to $3.9M; GAAP diluted EPS was $0.19 vs $1.13 a year ago.
  • Adjusted EBITDA decreased 41.3% to $18.4M from $31.3M, reflecting increased sales and marketing investments.
  • Modern Oral net sales grew 102.9% to $74.4M, now 49.2% of total net sales.
  • Stokers segment net sales rose 52.0% to $113.8M; Zig-Zag segment net sales fell 15.5% to $37.3M.
  • SG&A expenses increased 69.1% to $75.3M, driven by Modern Oral-related investments.
  • Company repurchased 167,161 shares for $10.0M at an average price of $59.82 per share.
  • Full-year 2026 guidance reaffirmed: Modern Oral gross sales $330-$350M, net sales $260-$270M, adjusted EBITDA $70-$80M.
  • Cash and liquidity: $251.3M cash, $48.7M net debt, $322.8M total liquidity as of September 30, 2026.

Financial Impact

Revenue beat by $3.3M (+2.2% vs consensus); adjusted EPS beat by $0.09 (+28.1% vs consensus). Profitability declined sharply with net income down 81.4% and adjusted EBITDA down 41.3%.

revenueepsnet incomeadjusted EBITDASG&A expenses

Segment Breakdown

SegmentRevenueGrowth
Stokers Products$113.8M+52.0%
Zig-Zag Products$37.3M-15.5%

Risk Factors

  • Profitability pressure from elevated sales and marketing investments may persist.
  • Zig-Zag segment continues to decline, down 15.5% YoY.
  • FDA PMTA costs remain a recurring expense ($3.2M in Q3 2026).
  • Operating cash flow for nine months was only $9.4M, down from $32.5M a year ago.

Market Snapshot

Exchange
NYSE
Sector
Tobacco Products
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-035713
Document: tpb20260827_8k.htm0001437749-26-035713
Document: 0001437749-26-035713-index-headers.html0001437749-26-035713
Document: 0001437749-26-035713-index.html0001437749-26-035713
Document: 0001437749-26-035713.txt0001437749-26-035713
8-K Data (Synthetic)0001437749-26-035713

Track record

5 reports on TPB

Performance horizon
Filters
  1. Nov 16, 2026today S-3ASR Neutral 3/10 Entry $55.87 Now $49.67 −11.09% settles Dec 15
  2. Nov 9, 20267d ago 8-K Mixed 5/10 Viewing Entry $63.26 Now $49.67 −21.48% settles Dec 8
  3. Aug 4, 202614w ago 8-K Neutral 5/10 Entry $82.48 to $77.72 Now $49.67 −39.78% ▼ −5.77% −4.53% vs SPY
  4. May 7, 202627w ago 8-K Mixed 6/10 Entry $90.22 to $86.24 Now $49.67 −44.95% ▼ −4.41% −7.55% vs SPY
  5. Feb 28, 202637w ago Institutional Cluster Neutral 4/10 Entry $108.41 to $86.22 Now $49.67 −54.18% ▼ −20.47% −12.53% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens in 8h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026